KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$28
152% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Needham
Needham
Serge Belanger
60% 1-yr KALV win rate
12 Sep ‘25 1 month ago
JMP Securities
JMP Securities
Jonathan Wolleben
60% 1-yr KALV win rate
12 Sep ‘25 1 month ago